3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

Orange chemical hailed as a treatment for AIDS

AIDS/HIVSep 27, 05

An Australian pharmaceutical company said on Tuesday a naturally occurring chemical extracted from oranges can be used to treat HIV/AIDS, influenza, SARS and the common cold.

Citrofresh International Ltd. said Europe’s Retroscreen Virology Laboratory had found its Citrofresh bioflavanoid compound to be effective against the HIV-1 virus, the human influenza A virus including Avian influenza or bird flu, the Urbani SARS virus and the human rhinovirus.

It did not say whether the results had been independently verified or whether they would be published.

Shares in the anti-virus treatment developer, with a market value of A$20 million ($15 million), more than tripled to A$0.70, prompting a trading halt in its shares as it prepared more information, expected to be released before the market opens on Thursday.

Bioflavonoids are a group of chemical compounds naturally found in certain fruits, vegetables, teas, wines, nuts, seeds, and roots with anti-oxidant and anti-inflammatory properties. However, they are usually derived from citrus fruit rinds.

“Retroscreen Virology confirmed that Citrofresh exhibits significant (viricidal) activity against all four viruses tested,” the company said in a statement to the Australian Stock Exchange.

Citrofresh, which sells anti-bacterial products for the food industry, provided no details of the results of tests it commissioned from Retroscreen Virology.

Shares in Citrofresh, which could not be reached for comment, were off their highs at A$0.535, when the trading halt was imposed, still more than double its A$0.21 close on Monday.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
  Cell-associated HIV mucosal transmission: The neglected pathway
  Offering option of initial HIV care at home increases use of ART
  HIV-1 movement across genital tract cells surprisingly enhanced by usurping antibody response
  Indonesia probes Bali tattoo HIV infection report
  Obama raises U.S. goal on fighting AIDS
  New device to test blood can spot cancer cells, HIV on the fly
  Rare HIV-positive individuals shed light on how body could effectively handle infection
  New research examines how HIV infections occur on the molecular level
  An answer to a longstanding question: How HIV infection kills T cells
  Researchers say uncover HIV, insulin resistance link
  Beatrice Hahn and George Shaw, Pioneers in HIV Research, to Join Penn Medicine

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site